Lion Corporation (4912) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
16 Sep, 2026Executive summary
Net sales and profits increased for the first time in four years, with consolidated net sales rising 2.5% year-on-year to ¥412.9 billion and operating income up 30.8%, driven by strong overseas growth and profit structure reforms.
Overseas sales, especially in China, Southeast Asia, Thailand, and Malaysia, offset domestic declines and drove consolidated growth.
Profit structure reforms, including price optimization, cost reductions, and portfolio changes, contributed to exceeding profit targets.
Core operating income and profit attributable to owners of the parent both rose significantly, surpassing forecasts due to higher overseas sales and structural reforms.
New product launches in Japan and successful portfolio reforms improved profitability.
Financial highlights
Net sales: ¥412.9 billion (+2.5% YoY); core operating income: ¥26.3 billion (+30.8%); operating profit: ¥28.3 billion (+38.4%); profit attributable to owners: ¥21.1 billion (+44.9%); EPS: ¥76.51 (+48.8%).
EBITDA: ¥45.1 billion (+18.8% YoY); EBITDA margin: 10.9% (up 1.5pp YoY).
Gross profit rose by ¥2.5 billion mainly from overseas sales, while price revisions added ¥4.2 billion.
Cost reductions totaled ¥2.8 billion, mainly from raw materials.
Total assets: ¥497,167 million; equity ratio: 59.1%; cash and cash equivalents at year-end: ¥102,240 million.
Outlook and guidance
Fiscal 2025 forecast: net sales ¥420.0 billion (+1.7%), core operating income ¥30.0 billion (+13.9%), operating profit ¥35.0 billion (+23.3%), profit attributable to owners ¥25.0 billion (+17.9%), EPS ¥90.24 (+17.9%).
Overseas business expected to drive growth with a CAGR of 7.2%; consolidated sales growth target is 3% per year.
Key 2027 targets: net sales ¥450.0 billion, EBITDA margin 13%+, ROIC 8–9%, EPS CAGR 11%+.
Dividend to increase to ¥30 per share, payout ratio at 33–35.3%, with partial treasury stock cancellation planned.
New medium-term plan (Vision2030 2nd STAGE) focuses on profitability and overseas growth.
Latest events from Lion Corporation
- Prioritizing high-value oral care and local leadership to drive profitable growth in Asia.4912
Investor update - Profits and sales surged, driven by overseas growth and price increases.4912
Q2 2024 - Core operating income surged 47.8% on modest sales growth, led by overseas expansion.4912
Q3 2024 - Sales and profits increased year-over-year, driven by overseas growth and higher dividends.4912
Q1 2025 - Core operating income rose 32.3% as overseas expansion and margin gains continued.4912
Q2 2025 - Profits surged on higher value-added sales and Southeast Asia growth; forecasts unchanged.4912
Q3 2025 - 2025 profit and margin growth exceeded targets; 2026 aims for further gains and higher dividends.4912
Q4 2025 - Q1 sales and profit rose 5.3%, led by oral care and overseas gains despite cost headwinds.4912
Q1 2026 - Strong sales and profit growth led by Oral Healthcare and overseas gains, with higher dividend.4912
Q2 2026